SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-19-040484
Filing Date
2019-11-05
Accepted
2019-11-05 17:16:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5.htm 424B5 926289
2 GRAPHIC gwhe0pansxnk000003.jpg GRAPHIC 3875
3 GRAPHIC gwhe0pansxnk000002.jpg GRAPHIC 94747
4 GRAPHIC gwhe0pansxnk000005.jpg GRAPHIC 2847
5 GRAPHIC gwhe0pansxnk000004.jpg GRAPHIC 37816
6 GRAPHIC gwhe0pansxnk000001.jpg GRAPHIC 2847
  Complete submission text file 0001564590-19-040484.txt   1123689
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233056 | Film No.: 191194296
SIC: 2834 Pharmaceutical Preparations